Article Text
PostScript
Letter
Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases
Statistics from Altmetric.com
Footnotes
Funding This research has been funded by the Fund for Scientific Research – Flanders. XB is a senior clinical investigator of the Fund for Scientific Research – Flanders.
Competing interests None.
Ethics approval This study was conducted with the approval of the University Hospitals, Leuven.
Provenance and peer review Not commissioned; not externally peer reviewed.
Linked Articles
- PostScript